Search Results for babylon health

TTA’s Summer’s Unofficial Kickoff: Pear’s bankruptcy fire sale, Bright’s last ditch moves with stock & Zipnosis sale, Oracle Cerner’s hospital problem, some light in global digital funding, more!

...Health drama goes on) Babylon Health ‘Take Private Proposal’ includes London High Court administration request (The real dirt in the 8-K) Mid-week roundup: DEA extends telehealth prescribing waiver to November; telehealth usage continues to erode; NextGen EHR hacked, 1M records breached (A short stay of sentence for telemental health prescribers dependent on controlled substances) Babylon Health to go private in June as shares plummet, Q1 loss increases 117% (AlbaCore taking over? Shares are a buck!) A week where a Gimlet Eye was needed. CVS closed on Oak Street, but it needs work. ChatGPT punctured on ’empathy’, companies rearranged and offloaded... Continue Reading

TTA’s Spring Warmup 2: closer look at Kaiser-Geisinger, VA renews Oracle contract, Holmes to prison 30 May, Envision’s Ch. 11, Validic-Trapollo, Meta Pixel in court, CVS shuts clinical trials, fundings, more!

...Trouble With Harry ;-) is mainly around Former Digital Health Darling Babylon Health, going private from a cracked SPAC, reorganization…and administration? The Cano Health BOD soap opera continues with a big loss. DEA gives a breather to telemental health prescribers. Syneos proves that CROs are golden, but Envision staffing not. And a big EHR hack hits NextGen. Week-end roundup: Cano Health’s $60M loss and divesting, Oscar Health exits CA, UCSF Meta Pixel lawsuit narrows, Syneos goes private for $7.1B, Envision nears Ch. 11, Australia’s A$429M EHR modernization funded (Cano Health drama goes on) Babylon Health ‘Take Private Proposal’ includes London... Continue Reading

TTA’s Spring Warmup: Babylon’s reorg to private company, Cano Health’s big loss, DEA extends prescribing waiver, Australia’s EHR getting modernized, Syneos $7.1B, Envision Ch. 11, more!

...modernization funded (Cano Health drama goes on) Babylon Health ‘Take Private Proposal’ includes London High Court administration request (The real dirt in the 8-K) Mid-week roundup: DEA extends telehealth prescribing waiver to November; telehealth usage continues to erode; NextGen EHR hacked, 1M records breached (A short stay of sentence for telemental health prescribers dependent on controlled substances) Babylon Health to go private in June as shares plummet, Q1 loss increases 117% (AlbaCore taking over? Shares are a buck!) A week where a Gimlet Eye was needed. CVS closed on Oak Street, but it needs work. ChatGPT punctured on ’empathy’, companies... Continue Reading

Babylon Health ‘Take Private Proposal’ includes London High Court administration request

An added fillip to Babylon Health’s going private under a ‘Take Private Proposal’ is the inclusion of administration in the UK. This was revealed in their 8-K (001-40952) filed on Wednesday with the Securities and Exchange Commission (SEC). It states that the Framework Implementation Agreement ‘contemplates’ that part of the Take Private Proposal will involve the appointment of administrators, the British form of the US Chapter 11 reorganization procedure. Specifically, the Babylon Holdings Limited board will request that administrators be appointed by the High Court in London. These administrators will then supervise the transfer of assets from Babylon Holdings Limited... Continue Reading

Babylon Health to go private in June as shares plummet, Q1 loss increases 117%

Babylon Health revealed its long-expected move to go back private, in conjunction with rising revenue, but also losses. Today (10 May) Babylon announced an agreement between it and AlbaCore Capital LLP that provided interim funding of $34.5 million. This buys time to implement a framework agreement between Babylon and AlbaCore to restructure and recapitalize the company to strengthen their balance sheet and provide additional liquidity. The ‘Take Private Proposal’ has the core operating subsidiaries of Babylon returning to private ownership as the ‘Go-Forward Business’ and sold to a newly formed entity capitalized by AlbaCore and other investors. Their additional debt... Continue Reading

Digital health’s funding time machine dialed back to 2019–before the SVB implosion: Rock Health

...in toto, in parts, or merger.) According to this chart shown by Arundhati Parmar, MedCity News’ editor-in-chief, during his VC panel at ViVE [TTA 31 Mar], only two of 17 publicly traded digital health companies that went public have share prices in excess of their IPO: Progyny (also profitable) and HealthEquity. Many are near or below the critical $1.00 mark. (This chart does not include Babylon Health which is trading around $5 and reorganizing to become a US company.) He also pointed out that only two of the 17 are profitable. These deals now also come with strings attached: valuation... Continue Reading

Breaking: Amazon closes One Medical $3.9B buy, despite loose ends–and is the Antitrust Bear being poked?

...in multiple states. Example: Oregon approved it, but with multiple stipulations [TTA 6 Jan]–and there are only five One Medical clinics in Oregon. States like New York, Massachusetts, Connecticut, and California are not exactly pushovers for approval, with California alone having two approval entities. Congress is increasingly feisty on data privacy–consumer health information and its misuse in telehealth [TTA 9 Feb]. Will this be ‘buy now, regret later’, a lá Teladoc’s expensive acquisition of Livongo, or Babylon Health going public with a SPAC? Is this a clever trap laid for Amazon? Amazon is already under a Federal and state microscope... Continue Reading

Mid-week news roundup: Parsa admits Babylon SPAC was ‘big mistake’, FTC’s strategy on GoodRx action, Oracle signs Accenture for VA training, Constellation delays ’22 reports, Emirates Health launches Care.ai and Digital Twin

Regrets? Babylon has a few. A short but surprising interview in Mobihealthnews by Ali Parsa will give Readers an idea of the bubbly mindset of 2020-21 and the crises that followed for some companies. Babylon had 400% growth, then felt it had to go public via a SPAC in October 2021. It cost them a lot, including losing US shareholders, yet being listed on the NYSE. Parsa admitted “But in hindsight, that was a very big mistake. There’s no question.” While their revenue has continued to climb, on target to hit over $1 billion this year as of January, the... Continue Reading

Interesting pickups from JPM on CVS, Talkspace, Veradigm backs Holmusk, ‘misunderstood’ Babylon Health; six takeaways

...health plans. Talkspace has some distance to go, quickly, with a loss through Q3 2022 of $61 million on revenues of $89 million and a share price today of $0.74, which means eventual delisting from Nasdaq. Is a quick buy in their future? Veradigm, still settling in on their new corporate name, has its own bet on behavioral health data on the analytics side, with a lead investment in Holmusk‘s $45 million Series B. Holmusk will pull in de-identified patient data from Veradigm to their NeuroBlu Database. Release And on to Babylon Health, where Ali Parsa must feel like Eric... Continue Reading

News roundup: Babylon Health Q3 revenue up 3.9x; surprise–DOJ to appeal UHG-Change buy approval; Walmart loses senior health exec Pegus to JPM

...$1.05 billion to $1.1 billion. Babylon is selling Meritage Medical Network, an independent physician association (IPA) based in Northern and Central California with 1,800 providers in six counties serving 90,000 patients, advised by a major investment bank. They will also comply with SEC reporting requirements for a domestic issuer versus previously as a foreign private issue. Babylon will report its Q4 and 2022 yearend results under U.S. GAAP. They are also proceeding with a 25-to-1 reverse stock split to boost share price and prevent a NYSE delisting [TTA 13 Oct]. Mobihealthnews The Department of Justice (DOJ) wiped egg off its... Continue Reading